1. Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
   Mengjiao Zhou et al, 2022, Frontiers in Pharmacology CrossRef
2. Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
   Sosmitha Girisa et al, 2021, Molecular Biomedicine CrossRef